Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | EZN-4176 |
Synonyms | |
Therapy Description |
EZN-4176 is a locked nucleic acid antisense oligonucleotide that targets the androgen receptor (AR), potentially resulting in decreased tumor growth (PMID: 24169353, PMID: 22027692). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
EZN-4176 | EZN4176|EZN 4176|Androgen Receptor Antisense Oligonucleotide EZN-4176 | Antisense Therapy 13 | EZN-4176 is a locked nucleic acid antisense oligonucleotide that targets the androgen receptor (AR), potentially resulting in decreased tumor growth (PMID: 24169353, PMID: 22027692). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|